News
Is Pfizer Winning Its $43 Billion Bet?
Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Cigna Group (CI) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Cigna Group (NYSE: CI)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever
Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will
Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.
However, the
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem
Pfizer to Buy a GLP-1 Drugmaker? Here's Why You Shouldn't Count on That Happening
The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even
Pfizer (PFE) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2024 Earnings CallJul 30, 2024, 10:30 a.m. ET
Operator
Source Fool.com
Merck (MRK) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q2 2024 Earnings CallJul 30, 2024, 9:00 a.m. ET
Operator
Source Fool.com
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from
Why Koninklijke Philips Stock Jumped 14% Today
Koninklijke Philips (NYSE: PHG) stock surged 14.5% through 10:05 a.m. ET Monday after the company reported strong earnings this morning.
Analysts had forecast the Dutch medical devices company would
Prediction: This Will Be Pfizer's Next Big Move
Despite its impressive performance in 2020 and 2021, it's no secret that Pfizer (NYSE: PFE) is in the process of reinventing itself. Without much of the windfall from its coronavirus products
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
Biogen (NASDAQ: BIIB) built itself into a multiple sclerosis (MS) treatment giant over the years -- but as older blockbusters lost exclusivity, growth stalled. And last year, annual revenue dropped
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested
2 Magnificent Growth Stocks to Buy Right Now
Not all stocks have responded to the bull market in the some way. While many businesses have followed the broader trend of steadily rising, some stocks are trading down considerably and even coming
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't
3 Surprisingly Underrated Stocks to Buy Right Now
The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely.
Three Motley Fool contributors think
Centene (CNC) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q2 2024 Earnings CallJul 26, 2024, 8:30 a.m. ET
Operator
Source Fool.com
EQS-Adhoc: Merck KGaA: Strong 2nd Quarter, Guidance raised
Why DexCom Stock Is Crashing Today
Shares of DexCom (NASDAQ: DXCM) were crashing 39.9% lower as of 10:20 a.m. ET on Friday. The huge sell-off came after the continuous glucose monitoring (CGM) systems maker announced its
Better Buy: Abbott Laboratories vs. Intuitive Surgical
Investors looking for stocks that can go up want to turn their heads toward the medical technology industry. Demand for devices that enable minimally invasive surgical procedures and remote
DexCom (DXCM) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
DexCom (NASDAQ: DXCM)Q2 2024 Earnings CallJul 25, 2024, 4:30 p.m. ET
Operator
Source Fool.com